Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism

Hyung‐Goo Kim(Augusta University Health), Cheol‐Hee Kim(Chungnam National University), Dianalee McKnight, Jacqueline Gutierrez(Baylor College of Medicine), Fan Xia(Baylor Genetics), Sakkubai Naidu(Kennedy Krieger Institute), Zeyaul Islam(Qatar Cardiovascular Research Center), Eric Muller(Stanford Health Care), Gaëtan Lesca(Hospices Civils de Lyon), Jill A. Rosenfeld(Baylor College of Medicine), Erin Torti, Marianne McGuire(Baylor College of Medicine), Jonathan D. J. Labonne(Florida State University), Arthur Sorlin(Inserm), Il‐Keun Kong(Gyeongsang National University), Sonal Mahida(Kennedy Krieger Institute), Yline Capri(Assistance Publique – Hôpitaux de Paris), Lawrence C. Layman(Augusta University), Oliver Hummel(Max Delbrück Center), Daryl A. Scott(Baylor College of Medicine), Suneeta Madan‐Khetarpal(Children's Hospital of Pittsburgh), Duchwan Ryu(Northern Illinois University), Gerard Bénédicte(Hôpital Civil, Strasbourg), Vincent des Portes(Centre National de la Recherche Scientifique), Ange-Line Bruel, Prasanna R. Kolatkar(Hamad bin Khalifa University), Jason Brown(Augusta University), Franz Rüschendorf(Max Delbrück Center)
Molecular Autism
October 22, 2019
Cited by 49


Related Papers